A detailed history of China Universal Asset Management Co., Ltd. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 28,027 shares of IONS stock, worth $1.28 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
28,027
Previous 28,027 -0.0%
Holding current value
$1.28 Million
Previous $1.22 Million 0.08%
% of portfolio
0.16%
Previous 0.15%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$42.03 - $53.55 $480,360 - $612,022
11,429 Added 68.86%
28,027 $1.22 Million
Q4 2023

May 21, 2024

SELL
$43.39 - $51.63 $495,904 - $590,079
-11,429 Reduced 40.78%
16,598 $839,000
Q4 2023

Jan 23, 2024

BUY
$43.39 - $51.63 $560,945 - $667,472
12,928 Added 352.26%
16,598 $840,000
Q3 2023

May 21, 2024

BUY
$38.5 - $47.13 $69,107 - $84,598
1,795 Added 95.73%
3,670 $166,000
Q3 2023

Oct 30, 2023

BUY
$38.5 - $47.13 $69,107 - $84,598
1,795 Added 95.73%
3,670 $166,000
Q2 2023

May 21, 2024

SELL
$34.73 - $43.33 $2,153 - $2,686
-62 Reduced 3.2%
1,875 $76,000
Q2 2023

Jul 27, 2023

SELL
$34.73 - $43.33 $2,153 - $2,686
-62 Reduced 3.2%
1,875 $77,000
Q1 2023

May 21, 2024

BUY
$33.58 - $41.2 $16,588 - $20,352
494 Added 34.23%
1,937 $69,000
Q1 2023

Apr 27, 2023

BUY
$33.58 - $41.2 $16,588 - $20,352
494 Added 34.23%
1,937 $69,000
Q4 2022

May 21, 2024

SELL
$37.12 - $46.52 $986,798 - $1.24 Million
-26,584 Reduced 94.85%
1,443 $54,000
Q4 2022

Jan 31, 2023

BUY
$37.12 - $46.52 $4,231 - $5,303
114 Added 8.58%
1,443 $55,000
Q3 2022

Oct 21, 2022

BUY
$36.54 - $48.66 $48,561 - $64,669
1,329 New
1,329 $59,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $6.47B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.